Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  ILAR journal

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/ilar/ilu018PMID 24936033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of aspirin in cancer prevention.

  2025cited by this paper
• Textbook of bladder cancer

  2015influential reference
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.

  2014cited by this paper
• Metronomic chemotherapy

  2014cited by this paper
• Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver

  2014influential reference
• Molecular Imaging of Cyclooxygenase-2 in Canine Transitional Cell Carcinomas In Vitro and In Vivo

  2013cited by this paper
• Alterations of DNA methylome in human bladder cancer

  2013cited by this paper
• Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004-2008).

  2013cited by this paper
• Targeting folate receptors to treat invasive urinary bladder cancer.

  2013cited by this paper
• Detection of herbicides in the urine of pet dogs following home lawn chemical application.

  2013cited by this paper
• Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010).

  2013cited by this paper
• Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy

  2013cited by this paper
• Cancer Incidence in Korean Vietnam Veterans During 1992-2003: The Korean Veterans Health Study

  2013cited by this paper
• Neutering Dogs: Effects on Joint Disorders and Cancers in Golden Retrievers

  2013cited by this paper
• Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

  2013cited by this paper
• Implication of androgen receptor in urinary bladder cancer: a critical mini review.

  2013influential reference
• In vitro and in vivo experimental models as tools to investigate the efficacy of antineoplastic drugs on urinary bladder cancer.

  2013cited by this paper
• Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer

  2013cited by this paper
• Low-dose metronomic chemotherapy: a systematic literature analysis.

  2013cited by this paper
• Estrogen receptor-β expression and pharmacological targeting in bladder cancer

  2013influential reference
• DNMT1: an emerging target in the treatment of invasive urinary bladder cancer.

  2013cited by this paper
• Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial—an update

  2013cited by this paper
• Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity

  2013cited by this paper
• Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.

  2013cited by this paper
• Epidemiology and risk factors of urothelial bladder cancer.

  2013influential reference
• UTIs in small animal patients: part 2: diagnosis, treatment, and complications.

  2013cited by this paper
• Cutaneous Metastasis of Transitional Cell Carcinoma in 12 Dogs

  2013cited by this paper
• Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.

  2013cited by this paper
• Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.

  2013cited by this paper
• Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer.

  2012cited by this paper
• p63, CK7, PAX8 and INI‐1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high‐grade tumours of the renal collecting system

  2012cited by this paper
• Histologic grading of urothelial carcinoma: a reappraisal.

  2012influential reference
• NMR-based metabolomics study of canine bladder cancer.

  2012cited by this paper
• Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs.

  2012cited by this paper
• GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.

  2012cited by this paper
• Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

  2012cited by this paper
• Bladder tumors and aromatic amines - historical milestones from Ludwig Rehn to Wilhelm Hueper.

  2012cited by this paper
• The role of the androgen receptor in the development and progression of bladder cancer.

  2012cited by this paper
• Occupational Pesticide Exposures and Cancer Risk: A Review

  2012cited by this paper
• Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.

  2012cited by this paper
• Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach.

  2012cited by this paper
• Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines.

  2012cited by this paper
• Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

  2012cited by this paper
• Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review

  2012cited by this paper
• Chemotherapy in advanced bladder cancer: current status and future

  2011cited by this paper
• AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression

  2011cited by this paper
• Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.

  2011cited by this paper
• A decade of exploring the cancer epigenome — biological and translational implications

  2011cited by this paper
• Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand

  2011cited by this paper
• Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008).

  2011cited by this paper
• Multivariate statistical identification of human bladder carcinomas using ambient ionization imaging mass spectrometry.

  2011cited by this paper
• Diagnosis and Management of Urothelial Carcinoma of the Bladder

  2011cited by this paper
• Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development.

  2011cited by this paper
• Prevalence of telomerase activity in human cancer.

  2011cited by this paper
• Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological Behavior

  2011cited by this paper
• Expression and function role of DNA methyltransferase 1 in human bladder cancer

  2011cited by this paper
• Current treatment of metastatic bladder cancer and future directions

  2011cited by this paper
• Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.

  2011cited by this paper
• Telomere length and risk of incident cancer and cancer mortality.

  2010cited by this paper
• Urethral Carcinoma and Hyperplasia in Male and Female B6C3F1 Mice Treated With 3,3′,4,4′-Tetrachloroazobenzene (TCAB)

  2010cited by this paper
• Hormonal and Sex Impact on the Epidemiology of Canine Lymphoma

  2010cited by this paper
• Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine.

  2010cited by this paper
• Effects of Short-term Celecoxib Treatment in Patients with Invasive Transitional Cell Carcinoma of the Urinary Bladder

  2010cited by this paper
• Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder.

  2010cited by this paper
• Man's best friend becomes biology's best in show: genome analyses in the domestic dog.

  2010cited by this paper
• Diagnosis and Classification of Flat, Papillary, and Invasive Urothelial Carcinoma: The WHO/ISUP Consensus

  2010cited by this paper
• The origins of urothelial carcinoma

  2010cited by this paper
• Heterocyclic aromatic amine pesticide use and human cancer risk: Results from the U.S. Agricultural Health Study

  2009cited by this paper
• Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.

  2009cited by this paper
• Metronomic chemotherapy.

  2009cited by this paper
• The present and future burden of urinary bladder cancer in the world

  2009cited by this paper
• Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry.

  2009cited by this paper
• Cause-specific mortality of Dutch chlorophenoxy herbicide manufacturing workers

  2009cited by this paper
• Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study

  2009cited by this paper
• Uroplakins in urothelial biology, function, and disease.

  2009cited by this paper
• Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.

  2008cited by this paper
• Targeted drug delivery via folate receptors

  2008cited by this paper
• Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma.

  2008cited by this paper
• Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.

  2008cited by this paper
• Gene polymorphisms in bladder cancer.

  2008cited by this paper
• Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells

  2008cited by this paper
• Occupational risk factors

  2008cited by this paper
• Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

  2008cited by this paper
• 10. Tumors of the Urinary System

  2008cited by this paper
• Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate.

  2007cited by this paper
• Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic.

  2007cited by this paper
• Placental S100 (S100P) and GATA3: Markers for Transitional Epithelium and Urothelial Carcinoma Discovered by Complementary DNA Microarray

  2007cited by this paper
• Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light.

  2007cited by this paper
• A population study of neutering status as a risk factor for canine prostate cancer

  2007influential reference
• Epidemiology of urinary bladder cancer: from tumor development to patient’s death

  2007cited by this paper
• Promotion of bladder cancer development and progression by androgen receptor signals.

  2007cited by this paper
• Classification of canine urinary bladder urothelial tumours based on the World Health Organization/International Society of Urological Pathology consensus classification.

  2006cited by this paper
• Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.

  2006cited by this paper
• Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer.

  2006cited by this paper
• Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects

  2006cited by this paper
• Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers.

  2005cited by this paper
• Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder.

  2005cited by this paper
• Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

  2005cited by this paper
• Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.

  2005cited by this paper

• Radiation therapy as a treatment for urinary obstruction secondary to urothelial carcinoma in dogs.

  2026cites this paper
• Silent Threats: A Narrative Review of Urinary Bladder Cancer in Dogs and Cats—Epidemiology and Risk Factors

  2026influential citation
• Dogs as a Model for Cancer: An Update.

  2026cites this paper
• Polypoid Cystitis: A Retrospective Case‐Series of 112 Dogs

  2025cites this paper
• Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells

  2025cites this paper
• Urothelial genotoxicity of household chemicals in healthy canine urinary bladder organoids relative to observed urinary exposures in pet dogs

  2025cites this paper
• BRAF Mutation Analysis: A Retrospective Evaluation of 8365 Diagnostic Samples with a Special View on Canine Breeds (2018–2024)

  2025influential citation
• Outcomes of total cystectomy with medical treatment in canine urothelial carcinoma of the bladder trigone.

  2025cites this paper
• Anticancer potentials of chaga and notoginseng against dog bladder cancer organoids

  2025cites this paper
• Hypoxia-inducible factor 1α expression does not differ between canine urothelial carcinoma and normal urinary bladder tissue.

  2025cites this paper
• Comparative histologic survey and transcriptomic investigation into canine prostate carcinoma.

  2025cites this paper
• Methodological evaluation of ultrasound-guided modified traumatic catheterization in dogs with suspected urothelial carcinoma

  2025cites this paper
• Urinary lipid production in dogs with urothelial carcinoma.

  2025cites this paper
• B-Mode Ultrasonography and Acoustic Radiation Force Impulse Elastography in Evaluation of Urothelial Carcinoma in Dogs

  2025cites this paper
• Identification of metastasis-associated protein 1 (MTA1) as a new molecular marker for canine urothelial carcinoma

  2025cites this paper
• Sorafenib inhibits myeloid-derived suppressor cell infiltration in canine transitional cell carcinoma.

  2025cites this paper
• Anti-tumor effect of proteasome inhibitor on canine urothelial carcinoma

  2024cites this paper
• Comparative aspects of targeted sentinel lymph node mapping in veterinary and human medicine: opportunities for future research

  2024cites this paper
• Inflammatory myofibroblastic tumor in the urinary bladder in a dog.

  2024cites this paper
• Urothelial genotoxicity of environmental chemicals detected in the urine of healthy dogs and their owners

  2024cites this paper
• Bioprinted research models of urological malignancy

  2024cites this paper
• Large-scale genomic analysis of the domestic dog informs biological discovery

  2024cites this paper
• Diagnostic Value of Conventional Polymerase Chain Reaction for Detecting BRAF V595E Mutation in Liquid and Tissue Specimens of Canine Urothelial and Prostate Carcinomas

  2024cites this paper
• Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs.

  2024cites this paper
• Assessment of Tumor-Associated Tissue Eosinophilia (TATE) and Tumor-Associated Macrophages (TAMs) in Canine Transitional Cell Carcinoma of the Urinary Bladder

  2024influential citation
• Successful Management of Incompletely Resected Transitional Cell Carcinoma with Sorafenib Tosylate in a Dog.

  2024cites this paper
• Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy or radiation therapy or both: A retrospective observational study

  2024cites this paper
• Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1

  2024influential citation
• Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma.

  2024cites this paper
• A review of the current standing of microRNA expression in canine urothelial carcinoma.

  2024cites this paper
• Epigenetic regulation in muscle-invasive urothelial carcinoma of the bladder in the dog, a translational model of human cancer

  2024cites this paper
• Effects of trastuzumab emtansine on canine urothelial carcinoma cells in vitro and in vivo.

  2024cites this paper
• The effect of body size and inbreeding on cancer mortality in breeds of the domestic dog: a test of the multi-stage model of carcinogenesis

  2024cites this paper
• Pan-tumour analysis of COX-2 expression in dogs.

  2024cites this paper
• Neoangiogenesis markers in canine urothelial carcinomas: A cross‐sectional study

  2024cites this paper
• Clinicopathologic Characterization of Prostatic Cancer in Dogs

  2024cites this paper
• Subtotal traumatic penile amputation of unknown origin in a canine

  2024cites this paper
• Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer

  2023cites this paper
• Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma

  2023influential citation
• A Systematic Review of Canine Cystectomy: Indications, Techniques, and Outcomes

  2023influential citation
• Influence of three different closure techniques on leakage pressures and leakage location following partial cystectomies in normal dogs

  2023cites this paper
• Canine urothelial carcinoma: expression of Periostin in spontaneous canine urothelial carcinoma and its correlation with histological features

  2023cites this paper
• Evaluation of the safety and feasibility of electrochemotherapy with intravenous bleomycin as local treatment of bladder cancer in dogs

  2023cites this paper
• Association between cigarette smoke exposure and urinary bladder cancer in Scottish terriers in a cohort study.

  2023cites this paper
• Canine urothelial carcinoma: a pilot study of microRNA detection in formalin-fixed, paraffin-embedded tissue samples and in normal urine

  2023cites this paper
• Feasibility of laparoscopic stapled partial cystectomy in canine cadavers.

  2023cites this paper
• A Retrospective Clinico-Pathologic Study of 35 Dogs with Urethral Transitional Cell Carcinoma Undergoing Treatment

  2023cites this paper
• Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned Dogs

  2023cites this paper
• A case series of urinary bladder rhabdomyosarcoma in seven dogs

  2023cites this paper
• Diagnostic challenge in veterinary pathology: Detection of BRAFV595E mutation in a dog with follicular cystitis and flat urothelial lesion with atypia

  2023cites this paper
• Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans

  2023cites this paper
• Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology

  2023cites this paper
• The impact of urine collection method on canine urinary microbiota detection: a cross-sectional study

  2023cites this paper
• Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy

  2023cites this paper
• Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids

  2023cites this paper
• EFEITOS DA CANNABIS SATIVA NA QUALIDADE DE VIDA DO PACIENTE ONCOLÓGICO: RELATO DE CASO

  2023cites this paper
• A canine case of bladder urothelial carcinoma (transitional cell carcinoma) treated with a chemotherapeutic agent, a molecular targeted drug, and cyclooxygenase inhibitors

  2023cites this paper
• Comparative oncology: overcoming human cancer through companion animal studies

  2023cites this paper
• Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs

  2023cites this paper
• What is your diagnosis? Oral mass of a dog.

  2023cites this paper
• Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs.

  2023cites this paper
• Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption

  2023cites this paper
• Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma

  2022cites this paper
• Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma

  2022influential citation
• Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy

  2022influential citation
• Urothelial carcinoma with tonsillar metastasis in a dog

  2022cites this paper
• Beyond the Laboratory: Emerging Landscape of Animal Studies - the Influence of National Academies of Sciences Activities and Publications.

  2022cites this paper
• Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs

  2022cites this paper
• Leiomyosarcoma of urinary bladder in a Shih Tzu dog

  2022cites this paper
• Animal Models in Toxicologic Research: Dog

  2022cites this paper
• Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma

  2022influential citation
• Coincidence of v-raf murine sarcoma viral oncogene homolog B mutation (V595E) with phosphorylated v-raf murine sarcoma viral oncogene homolog B in urothelial carcinoma in dogs.

  2022cites this paper
• Prolonged Survival Following Treatment of Histiocytic Sarcoma of the Canine Urinary Bladder.

  2022cites this paper
• Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma

  2022cites this paper
• Vaginal swab cytology as a diagnostic tool for neoplasia of the lower urinary tract in 5 dogs.

  2022cites this paper
• Characteristics and Applications of Canine In Vitro Models of Bladder Cancer in Veterinary Medicine: An Up-to-Date Mini Review

  2022cites this paper
• Caveolin-1, GATA-3, and Ki67 expressions and their correlation with pathological findings in canine bladder urothelial carcinoma

  2022cites this paper
• Usefulness of squash preparation cytology in the diagnosis of canine urinary bladder carcinomas.

  2022cites this paper
• The Italian Network of Laboratories for Veterinary Oncology (NILOV) 2.0: Improving Knowledge on Canine Tumours

  2022cites this paper
• Advances and challenges of CAR T therapy and suitability of animal models (Review)

  2022cites this paper
• Label-free optical redox ratio from urinary extracellular vesicles as a screening biomarker for bladder cancer.

  2022cites this paper
• Diagnosis and Retrospective Analysis of 17 Canine Bladder Tumors

  2022cites this paper
• Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview

  2022cites this paper
• The miRNome of canine invasive urothelial carcinoma

  2022influential citation
• Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy

  2022cites this paper
• Establishment of a direct 2.5D organoid culture model using companion animal cancer tissues.

  2022cites this paper
• Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method.

  2022cites this paper
• Validation of a Liquid Biopsy Protocol for Canine BRAFV595E Variant Detection in Dog Urine and Its Evaluation as a Diagnostic Test Complementary to Cytology

  2022cites this paper
• Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs

  2022cites this paper
• Lymphoma of the urinary bladder with concomitant septic peritonitis in a dog

  2022cites this paper
• Establishment and characterization of urothelial carcinoma cell lines with and without BRAF mutation (V595E) in dogs

  2022cites this paper
• Canine models of human cancer: Bridging the gap to improve precision medicine.

  2022cites this paper
• Detection of Canine Urothelial Carcinoma Cells in Urine Using 5-Aminolevulinic Acid

  2022cites this paper
• Irreversible Electroporation Balloon Therapy for Palliative Treatment of Obstructive Urethral Transitional Cell Carcinoma in Dogs.

  2022cites this paper
• CULTURE AND MAINTENANCE OF URINE-DERIVED, 3-DIMENSIONAL CANINE TRANSITIONAL CELL CARCINOMA ORGANOIDS

  2021influential citation
• Ablation of Red Stable Transfected Claudin Expressing Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cell Lines by C-CPE Gold-Nanoparticle-Mediated Laser Intervention

  2021cites this paper
• Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence.

  2021cites this paper
• Evaluation of lymphocyte-specific PD-1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.

  2021cites this paper
• Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells.

  2021cites this paper
• The One Medicine concept: its emergence from history as a systematic approach to re-integrate human and veterinary medicine

  2021cites this paper